XTalks

FEBRUARY 22, 2022

A successful life science webinar engages the audience in a unique manner, drives the right kind of traffic and provides genuine value for attendees. Here are 5 trending life science webinar topics that have been resonating well with our audiences. Then view our past life science webinars here.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

NOVEMBER 12, 2024

World Pneumonia Day 2024 provides an opportunity to examine the latest advances in pneumonia treatment and prevention — and the role that healthcare and life sciences industries play in reducing its global impact. Preventive Strategies: Vaccination and Public Health Initiatives Vaccination is a cornerstone for pneumonia prevention.

Bacteria 110

Bacteria Life Science Vaccine Vaccination 110

XTalks

FEBRUARY 15, 2024

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine.

Life Science 115

Life Science Scientist Research Protein 115

XTalks

SEPTEMBER 12, 2023

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. Building the data-powered life sciences business .

Life Science 111

Life Science Regulation Genome Genomics 111

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation. Challenges in Women’s Leadership.

Life Science 105

Life Science Gene Therapy DNA Vaccine 105

XTalks

MARCH 25, 2021

Xtalks is proud to announce the launch of the Xtalks Life Science podcast. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Fresh Conversations About Life Science Topics. She focuses on news relating to the food industry and writes blogs on recruitment and HR in the life sciences.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

XTalks

MAY 8, 2024

Dr. Schaffner and Dr. Moore discussed the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation of a trivalent influenza vaccine strain selection, as opposed to a typical quadrivalent vaccine, with the 2024/2025 influenza season reflecting the removal of the B/Yamagata strain.

Life Science 101

Life Science Vaccine Vaccination Medicine 101

XTalks

FEBRUARY 21, 2024

Reichman recently held the position of Head of Global Vaccines Engineering Core Technologies and Asset Management at the GSK Vaccines headquarters in Belgium. Before that, he was the Senior Director of the Global GSK Vaccines Supply Chain. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 105

Life Science Development Antibody Vaccine 105

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccine Vaccination 98

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. COVID-19: The Pandemic and the Vaccines.

Life Science 98

Life Science Vaccine Vaccination Trials 98

XTalks

JULY 22, 2021

Soumya Swaminathan made comments in a press briefing about mixing and matching COVID-19 vaccines and how there is currently no data to support additional doses and boosters at this time. Misleading Headlines Lead to Confusion Over WHO Comments on Boosters and Mixing and Matching COVID-19 Vaccines.

Life Science 98

Life Science Vaccine Vaccination Scientist 98

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . The post UK Vaccine Taskforce head lifts lid on Novavax deal appeared first on.

Vaccine 141

Vaccine Vaccination Manufacturing Clinical Development 141

XTalks

JANUARY 22, 2025

Valneva SE, who developed the worlds first FDA-approved chikungunya vaccine , has now unveiled promising Phase III data for its single-shot chikungunya vaccine, IXCHIQ, in adolescents aged 12 to 17. IXCHIQ is the only licensed chikungunya vaccine in the US for adults aged 18 and older at increased risk of exposure to the virus.

Immune Response 59

Immune Response Vaccine Vaccination Trials 59

pharmaphorum

DECEMBER 22, 2022

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

Vaccine 122

Vaccine Vaccination Life Science Manufacturing 122

Pharma Times

OCTOBER 12, 2022

DIT to showcase Liverpool city region’s life sciences expertise which will also include manufacturing

Life Science 130

Life Science Vaccination Vaccine Manufacturing 130

pharmaphorum

JULY 18, 2022

MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single dose SARS-CoV-2 vaccine offered as an injectable and inhalant that allows ease of storage, an alternative option for individuals with needle phobias, and robust elongated CD4 and CD8 cellular response. Morgon, PharmD, LL.M, How it works. Regarding the BA.4

Vaccine 138

Vaccine Vaccination Development Immune Response 138

STAT News

JANUARY 19, 2023

Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica, involving a Scientologist CEO and secretive investor seeking redemption after the worst trade of his life. Read the rest…

Vaccine 115

Vaccine Vaccination Life Science RNA 115

pharmaphorum

MARCH 4, 2021

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. This will provide a major incentive to modernise, digitise and grow companies across the country.

Vaccine 105

Vaccine Vaccination Development Life Science 105

XTalks

JANUARY 8, 2021

The US Food and Drug Administration (FDA) released a statement this week about dosing schedules for COVID-19 vaccines, saying that any dose changes would be premature. The FDA therefore continues to recommend the two-dose regimens that both the BioNTech/Pfizer and Moderna vaccines require.

Vaccine 144

Vaccine Vaccination Clinical Trials Clinical Trials 144

BioSpace

AUGUST 18, 2021

Fueled by the highly contagious delta variant, life science companies have issued policies on COVID-19 vaccines, including verbiage around exemptions or solutions for medical objections.

Vaccine 97

Vaccine Vaccination Life Science 97

XTalks

JUNE 21, 2024

The US Food and Drug Administration (FDA) has green-lighted the first pneumonia vaccine specifically designed for adults 50 years of age and older. These numbers do not reflect the efficacies of the vaccines, which have not been compared head-to-head in any trial yet.

FDA Approval 108

FDA Approval Vaccine Vaccination Life Science 108

pharmaphorum

DECEMBER 24, 2020

The UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make a decision on a shot from Oxford University/AstraZeneca in the next few days. Just how this will be viewed by regulators is unclear, as are the plans to distribute the vaccine.

Vaccine 126

Vaccine Vaccination Regulation Life Science 126

pharmaphorum

JULY 1, 2021

Miruna Sasu lays out how real-world data is evolving in the post COVID-19 vaccine reality. . Only a year after the emergence of COVID-19, a handful of life science companies started publishing data on the encouragingly high efficacy of their vaccine candidates.

Vaccine 103

Vaccine Vaccination Development Life Science 103

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. This included more than £6bn ($7.3bn) being made available by the UK Government in November 2020 for the development and procurement of successful vaccines.

Vaccine 234

Vaccine Vaccination Bacteria Life Science 234

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccine 105

Vaccine Vaccination Life Science Regulation 105

Fierce Pharma

MARCH 6, 2024

s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country. s business environment for the life sciences industry, is directing £650 million into the Big Pharma’s home country. AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s

Life Science 120

Life Science Vaccination Vaccine 120

STAT News

FEBRUARY 16, 2023

What does it mean when a vaccine is “free”? We also dive into the latest news in the life sciences, including Moderna’s promise of no-cost Covid-19 vaccines and biotech entrepreneur Vivek Ramaswamy’s potential run for president. Is the pharmaceutical lobby on the ropes? Read the rest…

Vaccine 98

Vaccine Vaccination Life Science 98

XTalks

NOVEMBER 23, 2021

Canadian pharma and biotech contract development and manufacturing organization (CDMO) Biovectra has announced plans for building one of the first state-of-the-art mRNA vaccine and biomanufacturing facilities in Canada. Related: Medicago’s Plant-Based COVID-19 Vaccine Enters Human Trials. million, respectively.

Manufacturing 98

Manufacturing Vaccine Vaccination Drugs 98

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

Life Science 147

Life Science Branding Pharma Companies Production 147

BioSpace

MARCH 26, 2024

Moderna has entered into a development and commercialization funding agreement with asset management firm Blackstone Life Sciences to help advance its pipeline of flu vaccine candidates.

Life Science 114

Life Science Vaccine Vaccination Development 114

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

FEBRUARY 5, 2021

As COVID-19 vaccines continue to be in short supply around the world, pharma giants such as Bayer (Nasdaq: BAYRY ) are stepping up to help fulfill the need. Bayer has agreed to assist in the manufacturing of an mRNA-based coronavirus vaccine, CVnCOV, developed by fellow German biopharma company CureVac (Nasdaq: CVAC ).

Vaccine 116

Vaccine Vaccination Production Manufacturing 116

XTalks

MARCH 6, 2025

This expansion has boosted Canadas R&D and clinical capabilities and positioned the country as a global hub for life sciences innovation. In the workplace, Roche bolstered staff engagement by introducing flexible work initiatives that promote a healthy work-life balance. million in 2020 alone.

Life Science 59

Life Science Vaccine Vaccination Drugs 59

STAT News

JANUARY 26, 2023

We also chat about the latest news in the life sciences, including an FDA advisory meeting debating the necessity for annual Covid vaccinations, and a surprising, but perhaps not, rejection of Eli Lilly’s Alzheimer’s disease treatment. Read the rest…

Vaccine 98

Vaccine Vaccination Life Science Drugs 98

XTalks

NOVEMBER 9, 2020

SARS-CoV-2 Vaccines Inch Towards Regulatory Approval. Over the past month or so, investigators have been amassing data on SARS-CoV-2 candidate vaccines as quickly as possible and some of that data is making its way—ever so much more slowly—through regulatory agencies for official scrutiny.

Vaccine 105

Vaccine Vaccination Development Drugs 105

XTalks

OCTOBER 12, 2021

Last week, a study that “stumbled upon” a vaccine for rheumatoid arthritis (RA) was published in the Proceedings of the National Academy of Sciences. The vaccine was tested in rats and showed strong, immediate and long-lasting immune responses to confer protection against the disease. With the finding that 14-3-3?

Vaccine 105

Vaccine Vaccination Research Immune Response 105